Clinical Trial News and Research

RSS

Inflammation plays crucial role in preventing heart attacks and strokes, study reveals

Inflammation, long considered a dangerous contributor to atherosclerosis, actually plays an important role in preventing heart attacks and strokes, new research from the University of Virginia School of Medicine reveals.

20 Sep 2018

Rice seeds could hold key to preventing HIV infections

As incredible as it sounds, a rice paddy field could one day yield an inexpensive way to prevent HIV.

20 Sep 2018

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces that it has signed a Memorandum of Understanding with Brazil-based Oswaldo Cruz Foundation 'Fiocruz' for the development of viral vaccines.

20 Sep 2018

First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute

A Puerto Rican patient with X-linked retinitis pigmentosa (XLRP) is hoping to save his vision after an innovative gene therapy procedure at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine.

19 Sep 2018

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

An analysis of the NRG Oncology clinical trial NRG-GY003 suggests that adding ipilimumab, a monoclonal antibody that targets the protein receptor CTLA-4, to a regimen with the checkpoint inhibitor nivolumab could improve the proportion with tumor response and progression-free survival hazard rates for women with recurrent epithelial ovarian cancer.

19 Sep 2018

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector, a privately held biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the initiation of its Phase 1 trial called INFRONT, which is evaluating AL001, the company's product candidate for the treatment of a genetically-defined sub-population of patients with frontotemporal dementia.

19 Sep 2018

Leading nutritionist explains about different types of iron in oral supplements

Iron is the top nutritional deficiency in the world, as many as 80 percent of people do not have enough iron in their body according to the World Health Organization.

From BetterYou Ltd 19 Sep 2018

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later.

19 Sep 2018

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has received positive feedback, via written response, from the U.S. Food and Drug Administration regarding its development plans for AB-PA01, without the need for a Type B Pre-IND meeting.

19 Sep 2018

TGen and PNOC take part in launch of NIH-supported Kids First Data Resource Portal

As part of a national initiative to solve children's diseases, the Translational Genomics Research Institute and the Pacific Pediatric Neuro-Oncology Consortium are participating in the launch of the Kids First Data Resource Portal, which is supported by the National Institutes of Health .

19 Sep 2018

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Researchers at University of California School of Medicine are preparing to launch a novel clinical trial to examine the safety, efficacy and pharmacological properties of cannabis as a potential treatment for adults with essential tremor.

18 Sep 2018

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Alcon, the global leader in eye care and a division of Novartis, is expanding its extensive, global support of eye care professionals through the unveiling of the Alcon Experience Academy.

18 Sep 2018

Targeted Lung Denervation procedure significantly reduces COPD problems

First results from a clinical trial of a procedure to open obstructed airways in patients with chronic obstructive pulmonary disease have shown that it significantly reduces problems associated with the disease and is safe.

18 Sep 2018

Resveratrol decreases pain severity and levels of inflammatory biomarkers in osteoarthritis patients

In what researchers state is the first pilot clinical trial to assess the effects of resveratrol on pain severity and levels of inflammatory biomarkers in patients with mild to moderate knee osteoarthritis, the scientists compared treatment with a nonsteroidal anti-inflammatory drug combined with either resveratrol or placebo over 90 days.

18 Sep 2018

Investigational nasal influenza vaccine tested in children and teens

An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy 9- to 17-year-old children and teens has begun enrolling participants at a Vaccine and Treatment Evaluation Unit site at Saint Louis University, St. Louis, Missouri.

17 Sep 2018

Study confirms link between use of muscle relaxants and respiratory complications

Muscle relaxants are a necessary part of anesthesia during certain major operations. Studies have, however, hinted at respiratory risks connected with these drugs.

17 Sep 2018

Ensysce receives award from NIDA to undertake development of opioid overdose protection platform

Ensysce Biosciences Inc. today announced receipt of Notice of Award from the National Institute on Drug Abuse, a four year award to undertake the pre-clinical and clinical development of the company's opioid overdose protection platform MPAR

17 Sep 2018

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration has approved AJOVY injection for the preventive treatment of migraine in adults.

17 Sep 2018

Daily low-dose aspirin does not prolong healthy life in older people, study finds

In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia or persistent physical disability).

17 Sep 2018

Study shows cost-effectiveness of financial incentive program to control cholesterol

A program that offered financial incentives to both patients and their physicians to control low-density lipoproteins cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease, according to new research led by Harvard T.H. Chan School of Public Health.

14 Sep 2018

Clinical Trial News and Research

Inflammation plays crucial role in preventing heart attacks and strokes, study reveals

Rice seeds could hold key to preventing HIV infections

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

First U.S. patient treated with innovative gene therapy at Bascom Palmer Eye Institute

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Leading nutritionist explains about different types of iron in oral supplements

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

TGen and PNOC take part in launch of NIH-supported Kids First Data Resource Portal

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Targeted Lung Denervation procedure significantly reduces COPD problems

Resveratrol decreases pain severity and levels of inflammatory biomarkers in osteoarthritis patients

Investigational nasal influenza vaccine tested in children and teens

Study confirms link between use of muscle relaxants and respiratory complications

Ensysce receives award from NIDA to undertake development of opioid overdose protection platform

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

Daily low-dose aspirin does not prolong healthy life in older people, study finds

Study shows cost-effectiveness of financial incentive program to control cholesterol

eBook: Using iPSCs models for human disease research and drug discovery eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer